Remove Biotechnology Remove Prevention Remove Regulations
article thumbnail

FTC’s Proposed Non-Compete Rule: A Step in the Right Direction for Health Care and Biotechnology

Bill Of Health

By Aparajita Lath In January, the Federal Trade Commission (FTC) released a new draft rule that would categorically ban non-compete clauses — contractual terms between an employer and an employee that prevent subsequent employment at a competing firm — across the country.

article thumbnail

Actionable Insights from the International Collaborative Research Program in Bioscience Innovation & Law

Bill Of Health

It provides tailored legal and regulatory support to patients, researchers, businesses, and incubators, driving progress in healthcare and biotechnology. Legal challenges and fragmented regulations are holding back the potential of personalized medicine. In Nature Medicine , we recently explored practical technical and legal solutions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ChristianaCare Spins Out New Gene Editing Company, CorriXR Therapeutics

HIT Consultant

What You Should Know: – ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The CorriXR Therapeutics team includes experienced biotechnology executives and world-renowned scientists and clinicians. The executive team is led by Eric Kmiec, Ph.D.,

article thumbnail

No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge

Bill Of Health

IBM and Google) to biotechnology (e.g., Second, even if a license isn’t granted, Moderna’s public promise justified reliance by others, and Moderna is thus prevented from retracting that promise under the doctrine of “promissory estoppel.” Tesla and Toyota) to software (e.g, According to the U.S. Why Should We Care?

article thumbnail

Perspectives on Data Privacy for Direct-to-Consumer Health Apps

Bill Of Health

These apps provide a window into some of the key issues in the world of digital health — including data privacy, data access, data ownership, bias, and the regulation of health technology. Direct-to-consumer (DTC) health apps, such as apps that manage our diet, fitness, and sleep, are becoming ubiquitous in our digital world.

article thumbnail

From Regulation to Innovation: The Impact of the EU AI Act on XR and AI in Healthcare

Bill Of Health

The EU AI Act: A Blueprint for Safe AI Systems The EU’s AI Act , enacted in March 2024, sets a new benchmark for AI regulation with a risk-based classification system—ranging from unacceptable to minimal risk—that dictates stringent safety measures and upholds fundamental rights.

article thumbnail

Bioethics, Psychedelic Therapy Abuse, and the Risk of Ethics Washing

Bill Of Health

In the context of an organization like Gather Well—namely, a recent extension of a lineage that has failed to prevent, and even enabled, harm—bioethicists taking on ethics consultancies face complex challenges. Neşe Devenot, PhD is a Senior Lecturer in the University Writing Program at the Johns Hopkins University.